Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus

References

• American Diabetes Association. 12. Older adults: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl1):S168–S179. doi:10.2337/dc21-S012
   Web of Science ®Google Scholar
• Biessels GJ, Whitmer RA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2020;63(1):3–9. doi:10.1007/s00125-019-04977-9
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2(3):246–255. doi:10.1016/S2213-8587(13)70088-3
   PubMed Web of Science ®Google Scholar
• Schnaider BM, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004;63(10):1902–1907. doi:10.1212/01.wnl.0000144278.79488.dd
   Web of Science ®Google Scholar
• Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545. doi:10.1016/S2213-8587(20)30118-2
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Sharrett AR, Albert MS, et al. The Association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42(7):1248–1254. doi:10.2337/dc19-0120
   PubMed Web of Science ®Google Scholar
• You Y, Liu Z, Chen Y, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021;58(6):671–685. doi:10.1007/s00592-020-01648-9
   PubMed Web of Science ®Google Scholar
• Xu W, Caracciolo B, Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes. 2010;59(11):2928–2935. doi:10.2337/db10-0539
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–696. doi:10.1016/S1474-4422(19)30079-1
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. doi:10.1016/S1474-4422(13)70124-8
   PubMed Web of Science ®Google Scholar
• Li X, Yuan J, Qin W, et al. Higher total cerebral small vessel disease burden was associated with mild cognitive impairment and overall cognitive dysfunction: a propensity score-matched case-control study. Front Aging Neurosci. 2021;13:695732. doi:10.3389/fnagi.2021.695732
   PubMed Web of Science ®Google Scholar
• Staals J, Makin SD, Doubal N, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–1234.
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Nobili F, Teunissen CE, Simo R, Scheltens P. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol. 2020;19(8):699–710. doi:10.1016/S1474-4422(20)30139-3
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Smith EE, Ramasundarahettige C, et al. Diabetes, brain infarcts, cognition, and small vessels in the Canadian Alliance for Healthy Hearts and Minds Study. J Clin Endocrinol Metab. 2021;106(2):e891–e898. doi:10.1210/clinem/dgaa815
   Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Teng Z, Feng J, Qi Q, et al. Long-term use of metformin is associated with reduced risk of cognitive impairment with alleviation of cerebral small vessel disease burden in patients with Type 2 diabetes. Front Aging Neurosci. 2021;13:773797. doi:10.3389/fnagi.2021.773797
   PubMed Web of Science ®Google Scholar
• Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683–1689. doi:10.1212/wnl.43.9.1683
   PubMed Web of Science ®Google Scholar
• Lee SH, Bae HJ, Ko SB, et al. Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes. J Neurol Neurosurg Psychiatry. 2004;75(3):423–427. doi:10.1136/jnnp.2003.015990
   PubMed Web of Science ®Google Scholar
• Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759–1766. doi:10.1212/WNL.0b013e3181c34a7d
   PubMed Web of Science ®Google Scholar
• Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450–454. doi:10.1161/STROKEAHA.109.564914
   PubMed Web of Science ®Google Scholar
• Staals J, Booth T, Morris Z, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 2015;36(10):2806–2811. doi:10.1016/j.neurobiolaging.2015.06.024
   PubMed Web of Science ®Google Scholar
• Huijts M, Duits A, van Oostenbrugge RJ, et al. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. a study in first-ever lacunar stroke and hypertensive patients. Front Aging Neurosci. 2013;5:72. doi:10.3389/fnagi.2013.00072
   PubMed Web of Science ®Google Scholar
• Lau KK, Li L, Schulz U, et al. Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts. Neurology. 2017;88(24):2260–2267. doi:10.1212/WNL.0000000000004042
   PubMed Web of Science ®Google Scholar
• Kim JM, Park KY, Kim HR, et al. Association of bone mineral density to cerebral small vessel disease burden. Neurology. 2021;96(9):e1290–e1300. doi:10.1212/WNL.0000000000011526
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008
   PubMed Web of Science ®Google Scholar
• Lu J, Li D, Li F, et al. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol. 2011;24(4):184–190. doi:10.1177/0891988711422528
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7
   PubMed Web of Science ®Google Scholar
• Kullmann S, Kleinridders A, Small DM, et al. Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diabetes Endocrinol. 2020;8(6):524–534. doi:10.1016/S2213-8587(20)30113-3
   Web of Science ®Google Scholar
• Chen YC, Lu BZ, Shu YC, Sun YT. Spatiotemporal dynamics of cerebral vascular permeability in Type 2 diabetes-related cerebral microangiopathy. Front Endocrinol. 2021;12:805637. doi:10.3389/fendo.2021.805637
   Web of Science ®Google Scholar
• Quick S, Moss J, Rajani RM, Williams A. A vessel for change: endothelial dysfunction in cerebral small vessel disease. Trends Neurosci. 2021;44(4):289–305. doi:10.1016/j.tins.2020.11.003
   PubMed Web of Science ®Google Scholar
• Low A, Mak E, Rowe JB, Markus HS, O’Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53:100916. doi:10.1016/j.arr.2019.100916
   PubMed Web of Science ®Google Scholar
• Hamilton O, Backhouse EV, Janssen E, et al. Cognitive impairment in sporadic cerebral small vessel disease: a systematic review and meta-analysis. Alzheimers Dement. 2021;17(4):665–685. doi:10.1002/alz.12221
   PubMed Web of Science ®Google Scholar
• Mestre H, Kostrikov S, Mehta RI, Nedergaard M. Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond). 2017;131(17):2257–2274. doi:10.1042/CS20160381
   Web of Science ®Google Scholar
• Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17(11):1016–1024. doi:10.1016/S1474-4422(18)30318-1
   PubMed Web of Science ®Google Scholar
• Zhang L, Chopp M, Jiang Q, Zhang Z. Role of the glymphatic system in ageing and diabetes mellitus impaired cognitive function. Stroke Vasc Neurol. 2019;4(2):90–92. doi:10.1136/svn-2018-000203
   Google Scholar
• Zhao H, Wang F, Luo GH, et al. Assessment of structural brain changes in patients with type 2 diabetes mellitus using the MRI-based brain atrophy and lesion index. Neural Regen Res. 2022;17(3):618–624. doi:10.4103/1673-5374.320996
   Web of Science ®Google Scholar
• Choi EY, Park YW, Lee M, et al. Magnetic resonance imaging-visible perivascular spaces in the basal ganglia are associated with the diabetic retinopathy stage and cognitive decline in patients With Type 2 diabetes. Front Aging Neurosci. 2021;13:666495. doi:10.3389/fnagi.2021.666495
   PubMed Web of Science ®Google Scholar
• Imamine R, Kawamura T, Umemura T, et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract. 2011;94(1):91–99. doi:10.1016/j.diabres.2011.06.014
   PubMed Web of Science ®Google Scholar
• van Gennip A, Stehouwer C, van Boxtel M, et al. Association of Type 2 diabetes, according to the number of risk factors within target range, with structural brain abnormalities, cognitive performance, and risk of dementia. Diabetes Care. 2021;44(11):2493–2502. doi:10.2337/dc21-0149
   Web of Science ®Google Scholar
• Mankovsky B, Zherdova N, van den Berg E, Biessels GJ, de Bresser J. Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus. Diabet Med. 2018;35(12):1663–1670. doi:10.1111/dme.13800
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Wang J, et al. White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients. Diabetes. 2014;63(11):3596–3605. doi:10.2337/db14-0342
   PubMed Web of Science ®Google Scholar
• Jimenez-Balado J, Riba-Llena I, Abril O, et al. Cognitive impact of cerebral small vessel disease changes in patients with hypertension. Hypertension. 2019;73(2):342–349. doi:10.1161/HYPERTENSIONAHA.118.12090
   Web of Science ®Google Scholar
• Zhou H, Yang J, Xie P, et al. Cerebral microbleeds, cognitive impairment, and MRI in patients with diabetes mellitus. Clin Chim Acta. 2017;470:14–19. doi:10.1016/j.cca.2017.04.019
   PubMed Web of Science ®Google Scholar